Biblio
Found 46 results
Author [ Title] Type Year Filters: Author is Kolluri, Siva Kumar [Clear All Filters]
“Activation of the Aryl Hydrocarbon Receptor by 10-Cl-BBQ Prevents Insulitis and Effector T Cell Development Independently of Foxp3+ Regulatory T Cells in Nonobese Diabetic Mice.”, J Immunol, vol. 196, no. 1, pp. 264-73, 2016.
, “AhR activation increases IL-2 production by alloreactive CD4 T cells initiating the differentiation of mucosal-homing Tim3 Lag3 Tr1 cells.”, Eur J Immunol, vol. 47, no. 11, pp. 1989-2001, 2017.
, “Alternate glucocorticoid receptor ligand binding structures influence outcomes in an in vivo tissue regeneration model”, Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, vol. 156, no. 2, pp. 121 - 129, 2012.
, , “The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor”, PLoS ONE, vol. 5, no. 10, p. e13128, 2010.
, “The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor.”, PLoS One, vol. 5, no. 10, 2010.
, “Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity”, Cancer research, vol. 61, pp. 4723–4730, 2001.
“The aryl hydrocarbon receptor is required for induction of p21cip1/waf1 expression and growth inhibition by SU5416 in hepatoma cells.”, Oncotarget, vol. 8, no. 15, pp. 25211-25225, 2017.
, “The Aryl Hydrocarbon Receptor Mediates Leflunomide-Induced Growth Inhibition of Melanoma Cells”, PLoS ONE, vol. 7, no. 7, p. e40926, 2012.
, “The aryl hydrocarbon receptor mediates leflunomide-induced growth inhibition of melanoma cells.”, PLoS One, vol. 7, no. 7, p. e40926, 2012.
, “The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells”, Cell death & disease, vol. 5, p. e1038, 2014.
, ,
“Cancer therapeutics based on BCL-2 functional conversion.”, Apoptosis, vol. 24, no. 1-2, pp. 1-2, 2019.
, “Complementation of Ah receptor deficiency in hepatoma cells: negative feedback regulation and cell cycle control by the Ah receptor”, Experimental cell research, vol. 226, pp. 154–163, 1996.
, “Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3”, Cell, vol. 116, pp. 527–540, 2004.
, “Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3”, Science, vol. 289, pp. 1159–1164, 2000.
“Determinants of Retinoid X Receptor Transcriptional Antagonism”, Journal of Medicinal Chemistry, vol. 47, no. 18, pp. 4360 - 4372, 2004.
, “Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro”, Toxicological sciences, p. kfq379, 2010.
, “Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism”, Journal of Pharmacology and Experimental Therapeutics, vol. 338, pp. 318–327, 2011.
, “Identification of a Raloxifene Analog That Promotes AhR-Mediated Apoptosis in Cancer Cells”, Biology (Basel), vol. 6, no. 4, 2017.
, “Identification of a Raloxifene Analog That Promotes AhR-Mediated Apoptosis in Cancer Cells.”, Biology (Basel), vol. 6, no. 4, 2017.
, “Improved in vivo targeting of BCL-2 phenotypic conversion through hollow gold nanoshell delivery.”, Apoptosis, 2019.
, “Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells.”, Oncotarget, vol. 9, no. 40, pp. 26072-26085, 2018.
, “Mapping of epitopes on porcine zona pellucida-3 alpha by monoclonal antibodies inhibiting oocyte-sperm interaction.”, Biology of reproduction, vol. 55, pp. 410–415, 1996.
, “Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells”, Molecular and cellular biology, vol. 23, pp. 8651–8667, 2003.
,